Future-ready technologies for sensing the stemness of circulating tumor cells.

NanomedicineAhead of Print EditorialFuture-ready technologies for sensing the stemness of circulating tumor cellsPradyumna Kumar Mishra & Prasan KaurPradyumna Kumar Mishra *Author for correspondence: E-mail Address: pkm_8bh@yahoo.co.ukhttps://orcid.org/0000-0002-0795-2819Division of Environmental Biotechnology, Genetics and Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, 462030, IndiaSearch for more papers by this author & Prasan KaurDivision of Environmental Biotechnology, Genetics and Molecular Biology, ICMR-National Institute for Research in Environmental Health, Bhopal, 462030, IndiaSearch for more papers by this authorPublished Online:10 Aug 2023https://doi.org/10.2217/nnm-2023-0066AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: artificial intelligencecirculating tumor cellsdisruptive technologiesepithelial-to-mesenchymal transitionnanobiosensorspersonalized medicinepoint-of-care assaystem cellstranslational medicinetranslational researchPapers of special note have been highlighted as: • of interest; •• of considerable interestReferences1. Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target. Ther. 5(1), 28 (2020).Crossref, Medline, Google Scholar2. Deng Z, Wu S, Wang Y, Shi D. Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine 83, 104237 (2022).Crossref, Medline, CAS, Google Scholar3. Bates M, Mohamed BM, Ward MP et al. Circulating tumour cells: the good, the bad and the ugly. Biochim. Biophys. Acta Rev. Cancer 1878(2), 188863 (2023).Crossref, Medline, CAS, Google Scholar4. Jiang M, Jin S, Han J et al. Detection and clinical significance of circulating tumor cells in colorectal cancer. Biomark. Res. 9(1), 85 (2021).Crossref, Medline, Google Scholar5. Huang Q, Wang Y, Chen X et al. Nanotechnology-based strategies for early cancer diagnosis using circulating tumor cells as a liquid biopsy. Nanotheranostics 2(1), 21–41 (2018). •• Discusses the challenges and potential applications of representative nanomaterials (e.g., magnetic nanoparticles, gold nanoparticles, silicon nanowires, nanopillars, carbon nanotubes, dendrimers, quantum dots, graphene oxide) and microfluidic chip technologies that incorporate nanoroughened surfaces.Crossref, Medline, Google Scholar6. Li W, Wang H, Zhao Z et al. Emerging nanotechnologies for liquid biopsy: the detection of circulating tumor cells and extracellular vesicles. Adv. Mater. 31(45), e1805344 (2019). • Summarizes recent developments in liquid biopsy nanomaterials, nanostructures, nanodevices and nanosensors with an emphasis on the identification and molecular characterization of circulating tumor cells and extracellular vesicles. Emerging microfluidic platforms for on-chip molecular analysis, detection and isolation are also provided.Crossref, Medline, CAS, Google Scholar7. Sun ZF, Chang Y, Xia N. Recent development of nanomaterials-based cytosensors for the detection of circulating tumor cells. Biosensors (Basel) 11(8), 281 (2021). •• Summarizes the most recent advances in surface-enhanced Raman scattering, chemiluminescence, electrochemistry, photo electrochemistry, fluorescence, colorimetry and other optical and electrochemical analytical methods for the detection of circulating tumor cells.Crossref, Medline, CAS, Google Scholar8. Mishra PK, Shandilya R. Nanophotonic biosensors as point-of-care tools for preventive health interventions. Nanomedicine (Lond.) 15(16), 1541–1544 (2020). • Deciphers the nanobiosensors as point-of-care tools for preventive health interventions for the end users that could precisely detect the molecular signatures in the human circulating bodily fluids with high reproducibility.Link, CAS, Google Scholar9. Habli Z, AlChamaa W, Saab R, Kadara H, Khraiche ML. Circulating tumor cell detection technologies and clinical utility: challenges and opportunities. Cancers (Basel) 12(7), 1930 (2020).Crossref, Medline, CAS, Google Scholar10. Wang J, Gao Z, Dong M et al. CdSe@CdS quantum dot-sensitized Au/α-Fe2O3 structure for photoelectrochemical detection of circulating tumor cells. Mikrochim. Acta. 190(6), 221 (2023).Crossref, Medline, CAS, Google Scholar11. Jou HJ, Chou LY, Chang WC et al. An automatic platform based on nanostructured microfluidic chip for isolating and identification of circulating tumor cells. Micromachines (Basel) 12(5), 473 (2021).Crossref, Medline, Google Scholar12. Yu Y, Yang Y, Wang F et al. Functional and biocompatible polymeric ionic liquid (PIL) – decorated immunomagnetic nanospheres for the efficient capture of rare number CTCs. Anal. Chim. Acta 1044, 162–173 (2018).Crossref, Medline, CAS, Google Scholar13. Abate MF, Jia S, Ahmed MG et al. Visual quantitative detection of circulating tumor cells with single-cell sensitivity using a portable microfluidic device. Small 15(14), e1804890 (2019).Crossref, Medline, Google Scholar14. Kamińska A, Szymborski T, Witkowska E et al. Detection of circulating tumor cells using membrane-based SERS platform: a new diagnostic approach for ‘liquid biopsy’. Nanomaterials (Basel) 9(3), 366 (2019).Crossref, Medline, CAS, Google Scholar15. Yang X, Mu D, Peng H et al. Research and application of artificial intelligence based on electronic health records of patients with cancer: systematic review. JMIR Med. Inform. 10(4), e33799 (2022).Crossref, Medline, Google Scholar16. Guo X, Lin F, Yi C et al. Deep transfer learning enables lesion tracing of circulating tumor cells. Nat. Commun. 13(1), 7687 (2022).Crossref, Medline, CAS, Google Scholar17. Hashemzadeh H, Shojaeilangari S, Allahverdi A, Rothbauer M, Ertl P, Naderi-Manesh H. A combined microfluidic deep learning approach for lung cancer cell high throughput screening toward automatic cancer screening applications. Sci. Rep. 11(1), 9804 (2021).Crossref, Medline, CAS, Google Scholar18. Ma J, Yang J, Jin Y et al. Artificial intelligence based on blood biomarkers including CTCs predicts outcomes in epithelial ovarian cancer: a prospective study. Onco. Targets Ther. 14, 3267–3280 (2021).Crossref, Medline, Google Scholar19. Ginghina O, Hudita A, Zamfir M et al. Liquid biopsy and artificial intelligence as tools to detect signatures of colorectal malignancies: a modern approach in patient's stratification. Front. Oncol. 12, 856575 (2022).Crossref, Medline, CAS, Google Scholar20. Gong H, Dai Q, Peng P. Cell-membrane-anchored DNA logic-gated nanoassemblies for in situ extracellular bioimaging. ACS Appl. Mater. Interfaces 14(38), 43026–43034 (2022).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Ahead of Print STAY CONNECTED Metrics Downloaded 5 times History Received 10 March 2023 Accepted 12 July 2023 Published online 10 August 2023 Information© 2023 Future Medicine LtdKeywordsartificial intelligencecirculating tumor cellsdisruptive technologiesepithelial-to-mesenchymal transitionnanobiosensorspersonalized medicinepoint-of-care assaystem cellstranslational medicinetranslational researchFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download